Industry news
News of the day
OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary
BEVERLY HILLS, Calif., Aug. 3, 2010 -- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI) announced today the launch of its wholly owned subsidiary, Oxis Consumer Products (OCP), focused on the development, marketing, promotion, and sales of direct to consumer brands. OCP will be responsible for sales, marketing and distribution of the recently announced ErgoFlex moreFrom Oranienburg to the rest of the world: global market launch of Daxas
September 01, 2010 -- Stefan Brinkmann, Managing Director of Nycomed GmbH, kicked off the German market launch of Daxas moreSEMBIOSYS ISSUED KEY U.S. PATENT FOR THE PRODUCTION OF APOLIPOPROTEINS IN PLANTS
CALGARY, Sept. 1, 2010 - SemBioSys Genetics Inc. (TSX:SBS) today announced that the United States Patent and Trade Mark Office has granted the Company U.S. patent 7,786,352 entitled "Methods for the Production of Apolipoproteins in Transgenic Plants". The granted patent claims include the methods for the expression of apolipoprotein (Apo) in plants, including Apo AI(Milano), the introduction of related chimeric nucleic acid into plant cells and producing plant cells capable of growing into... moreIndustry news search
Most Viewed
OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary
CULS Conversion and Additional Listing
Publication of Phase II trial results of NGR-hTNF in liver cancer by the British Journal of Cancer
From Oranienburg to the rest of the world: global market launch of Daxas
Latest news by therapeutic target
Cardiovascular
- Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
- Bayer
- Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
- More news...
Latest news by category
Intellectual Property
- SEMBIOSYS ISSUED KEY U.S. PATENT FOR THE PRODUCTION OF APOLIPOPROTEINS IN PLANTS
- StemCells, Inc's Technology Used to Create First Genetically Engineered Rat Derived from Rat Embryonic Stem Cells
- Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office
- More news...
Press releases
- Innocoll Announces Successful End-of-Phase 2 Meeting with FDA for XaraColl® and Agreement of the Phase 3 Program
- Innocoll Enters CollaGUARD® Distribution Partnership with Flynn Pharma Ltd in the UK and Inresa Arzneimittel GmbH in Germany
- APR Applied Pharma Research s.a., Labtec GmbH and Norgine BV Announce the Signature of an Exclusive Licensing Agreement under Which Norgine Will Market and Distribute Setofilm™
- More news...
PR Newswire
- Machine Preservation Significantly Improves Kidney Transplant Survival Over 3 Years Compared to Traditional box of ice
- Physicians Collect Incentives as MBC Guides its 100th Physician Practice to EHR Meaningful use
- TATAA Biocenter Expands Offerings using Roche´s RealTime ready Custom qPCR Assays and Panels
- More news...
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us